Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.37% is 73% below its 5-year average of 5.12%, near the low end of its 5-year range (1.37%–66.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 43.69% below its 12-month average of 2.43%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.37%.
DEBT TO ASSETS RATIO
1.37%
DEBT TO ASSETS RATIO AVG TTM
2.43%
DEBT TO ASSETS RATIO AVG 3Y
4.51%
DEBT TO ASSETS RATIO AVG 5Y
5.12%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-43.69%
CURRENT VS 3Y AVG
-69.69%
CURRENT VS 5Y AVG
-73.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.12%
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
+1040.07%
vs the sector median at left
Absci Corporation
Market Cap
$1.95B
Debt to Assets Ratio
1.37%
TTM Avg
2.43%
3Y Avg
4.51%
5Y Avg
5.12%
Market Cap
$1.96B
Debt to Assets Ratio
0.75%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.01B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.02B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.87B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.05B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Absci Corporation (ABSI) | $1.95B | 1.37% | 2.43% | 4.51% | 5.12% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | 0.75% | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $1.97B | 0.03% | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 0.07% | N/A | N/A | N/A |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 0.41% | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 0.04% | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 0.08% | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | 0.03% | N/A | N/A | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 0.03% | N/A | N/A | N/A |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | 0.73% | N/A | N/A | N/A |
Debt/Assets
1.4%
Debt/Equity
0.01
Current Ratio
10.63
Interest Coverage
-596.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.37% |
| 2026-03-31 | 2.26% |
| 2025-12-31 | 2.45% |
| 2025-09-30 | 2.54% |
| 2025-06-30 | 3.53% |
| 2025-03-31 | 3.84% |
| 2024-12-31 | 4.73% |
| 2024-09-30 | 5.10% |
| 2024-06-30 | 5.22% |
| 2024-03-31 | 5.18% |
| 2023-12-31 | 7.31% |
| 2023-09-30 | 7.51% |
| 2023-06-30 | 7.66% |
| 2023-03-31 | 7.18% |
| 2022-12-31 | 7.16% |
| 2022-09-30 | 7.75% |
| 2022-06-30 | 7.57% |
| 2022-03-31 | 4.61% |
| 2021-12-31 | 4.70% |
| 2021-09-30 | 4.84% |
| 2021-06-30 | 66.37% |
| 2021-03-31 | 65.06% |
| 2020-12-31 | 16.37% |
